YM872: A Selective, Potent and Highly Water‐Soluble α‐Amino‐3‐Hydroxy‐5‐Methylisoxazole‐4‐Propionic Acid Receptor Antagonist

This review focuses on the in vitro and in vivo neuropharmacology of YM872, a potential neuroprotective agent currently undergoing clinical trials in the United States (trial name: AMPA Receptor Antagonist Treatment in Ischemic Stroke — ARTIST). Its neuroprotective properties in rats and cats with i...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:CNS Drug Rev
Prif Awduron: Takahashi, Masayasu, Kohara, Atsuyuki, Shishikura, Jun‐ichi, Kawasaki‐Yatsugi, Sachiko, Ni, Jian Wei, Yatsugi, Shin‐ichi, Sakamoto, Shuichi, Okada, Masamichi, Shimizu‐Sasamata, Masao, Yamaguchi, Tokio
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Blackwell Publishing Ltd 2006
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6741659/
https://ncbi.nlm.nih.gov/pubmed/12481190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2002.tb00232.x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg